These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14327158)

  • 1. ON THE CONFIGURATION OF A LYSINE -VASOPRESSIN DIMER.
    SCHALLY AV; BARRETT JF
    J Am Chem Soc; 1965 Jun; 87():2497-9. PubMed ID: 14327158
    [No Abstract]   [Full Text] [Related]  

  • 2. REACTIONS OF CUPRIC ION WITH LYSINE VASOPRESSIN AND ACETYLLYSINE VASOPRESSIN.
    CAMPBELL BJ; CHU FS; HUBBARD S
    Biochemistry; 1963; 2():764-9. PubMed ID: 14075111
    [No Abstract]   [Full Text] [Related]  

  • 3. A COMPARISON OF THE EFFECTS OF 8-LYSINE-VASOPRESSIN, 1-DEAMINO-8-LYSINE-VASOPRESSIN AND 1-ACETYL-8-LYSINE-VASOPRESSIN ON THE BLOOD GLUCOSE LEVEL IN RABBITS.
    CASH WD; KAPLAN MH
    Endocrinology; 1964 May; 74():803-4. PubMed ID: 14168572
    [No Abstract]   [Full Text] [Related]  

  • 4. INACTIVATION OF ARGININE- AND LYSINE-VASOPRESSIN BY SLICES FROM DIFFERENT ZONES OF THE RAT KIDNEY AND BY RAT LIVER SLICES.
    THORN NA; WILLUMSEN NB
    Acta Endocrinol (Copenh); 1963 Dec; 44():545-62. PubMed ID: 14082543
    [No Abstract]   [Full Text] [Related]  

  • 5. SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER.
    SCHALLY AV; GUILLEMIN R
    J Biol Chem; 1964 Apr; 239():1038-41. PubMed ID: 14165903
    [No Abstract]   [Full Text] [Related]  

  • 6. [ACTIONS OF ACTH AND LYSINE-VASOPRESSIN ON SYNTHESIS AND RELEASE OF CORTICOSTERONE IN THE RAT--STUDY IN VITRO].
    MIALHE-VOLOSS C; KOCH B; DUCOMMUN P; FORTIER C
    Rev Can Biol; 1964 Dec; 23():469-72. PubMed ID: 14257893
    [No Abstract]   [Full Text] [Related]  

  • 7. A new method of coupling [8-lysine] vasopressin to agarose: the purification of neurophysins by affinity chromatography.
    Robinson IC; Edgar DH; Walker JM
    Neuroscience; 1976; 1(1):35-9. PubMed ID: 980248
    [No Abstract]   [Full Text] [Related]  

  • 8. On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin.
    GUILLEMIN R; SCHALLY AV; LIPSCOMB HS; ANDERSEN RN; LONG JM
    Endocrinology; 1962 Apr; 70():471-7. PubMed ID: 13902822
    [No Abstract]   [Full Text] [Related]  

  • 9. Diabetes insipidus treated with synthetic lysine vasopressin.
    BARLTROP D
    Lancet; 1963 Aug; 2(7302):276-8. PubMed ID: 13966719
    [No Abstract]   [Full Text] [Related]  

  • 10. Synthesis and biological properties of 1-desamino-8-lysine-vasopressin.
    KIMBROUGH RD; CASH WD; BRANDA LA; CHAN WY; DU VIGNEAUD V
    J Biol Chem; 1963 Apr; 238():1411-4. PubMed ID: 14032722
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis and biological properties of 1-acetyl-8-lysine-vasopressin.
    CASH WD; SMITH BL
    J Biol Chem; 1963 Mar; 238():994-7. PubMed ID: 14019074
    [No Abstract]   [Full Text] [Related]  

  • 12. EFFECT OF LYSINE VASOPRESSIN DIMERS ON BLOOD PRESSURE AND SOME ENDOCRINE FUNCTIONS.
    SCHALLY AV; BOWERS CY; KUROSHIMA A; ISHIDA Y; CARTER WH; REDDING TW
    Am J Physiol; 1964 Aug; 207():378-84. PubMed ID: 14205351
    [No Abstract]   [Full Text] [Related]  

  • 13. THE TREATMENT OF DIABETES INSIPIDUS WITH SYNTHETIC LYSINE-VASOPRESSIN BY INHALATION.
    MARTIN FI; MATHEW TH
    Med J Aust; 1964 Oct; 2():984-6. PubMed ID: 14226568
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of some activities of arginine vasopressin and lysine vasopressin on kidney function in conscious dogs.
    ALI MN
    Br J Pharmacol Chemother; 1958 Jun; 13(2):131-7. PubMed ID: 13536276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DIABETES INSIPIDUS. TREATMENT WITH 8-LYSINE VASOPRESSIN IN A NASAL SPRAY.
    CHIRMAN SB; KINSELL LW
    Calif Med; 1964 Jul; 101(1):1-3. PubMed ID: 14179526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DIABETES INSIPIDUS. DIFFICULTIES IN DIAGNOSIS AND TREATMENT; USE OF SYNTHETIC LYSINE-8 VASOPRESSIN IN PATIENTS INTOLERANT OF OTHER THERAPY.
    EISENBERG E
    Calif Med; 1965 May; 102(5):353-8. PubMed ID: 14290932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of synthetic lysine-vasopressin on plasma hydrocortisone levels in man.
    MCDONALD RK; PATRICK RW; WEISE VK
    Proc Soc Exp Biol Med; 1956 Nov; 93(2):348-9. PubMed ID: 13379507
    [No Abstract]   [Full Text] [Related]  

  • 18. A TRIAL OF PHENYL-LYSINE-VASOPRESSIN (OCTAPRESSIN) AS A HAEMOSTATIC AGENT.
    RAWSTRON RE; HUTCHINSON BR; MCNEILL TD
    N Z Med J; 1964 May; 63():297-300. PubMed ID: 14159619
    [No Abstract]   [Full Text] [Related]  

  • 19. TREATMENT OF DIABETES INSIPIDUS: SYNTHETIC LYSINE VASOPRESSIN NASAL SOLUTION.
    DINGMAN JF; HAUGER-KLEVENE JH
    J Clin Endocrinol Metab; 1964 Jun; 24():550-3. PubMed ID: 14187294
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of diabetes insipidus with 1-deamino-8-d-arginine vasopressin.
    Czakó L; Mezei G; László FA
    Acta Med Acad Sci Hung; 1975; 32(1):75-84. PubMed ID: 1233863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.